Search Results - "Kovacs, C J"

RgpF Is Required for Maintenance of Stress Tolerance and Virulence in Streptococcus mutans by Kovacs, C J, Faustoferri, R C, Quivey, Jr, R G

“…Bacterial cell wall dynamics have been implicated as important determinants of cellular physiology, stress tolerance, and virulence. In , the cell wall is…”
Get full text

Effects of cold high pressure densification on Cu sheathed Ba0.6K0.4Fe2As2 superconducting wire by Ding, Y., Li, G.Z., Yang, Y., Kovacs, C.J., Susner, M.A., Sumption, M.D., Sun, Y., Zhuang, J.C., Shi, Z.X., Majoros, M., Collings, E.W.

“…► Cu sheathed polycrystalline Ba0.6K0.4Fe2As2 superconducting wire was prepared. ► Cold high pressure densification was applied to a short sample before…”
Get full text

Cryogenic Electrical Properties of an Aluminum-Beryllium Nanocomposite by Kovacs, C. J., Bullard, T. J., Haugan, T. J., Sumption, M. D.

“…Many power distribution networks are desiring lightweight electrical conductors. Cryogenic hyperconducting aluminum (99.999%+ pure) is a competitive option to…”
Get full text

A Hematopoietic Stromal Lesion Associated with Fractionated Radiotherapy (FxRT): Time- and Dose-effects by KOVACS, C. J, EVANS, M. J, DALY, B. M

“…Earlier, we reported that the local exposure of femoral bone marrow to a clinically-relevant course of fractionated radiotherapy [FxRT; 2.0 Gy (q24h × 5)→74…”
Get full text

Increased permeability of psoriatic skin to the protein, plasminogen activator inhibitor 2 by GOULD, A. R, SHARP, P. J, SMITH, D. R, STEGINK, A. J, CHASE, C. J, KOVACS, J. C, PENGLIS, S, CHATTERTON, B. E, BUNN, C. L

“…The penetration and permeation of the recombinant protein plasminogen activator inhibitor type 2 (PAI-2) in two formulations, one containing a penetration…”
Get full text

Quench and stability of Roebel cables at 77 K and self-field: Minimum quench power, cold end cooling, and cable cooling efficiency by Kovacs, C.J., Majoros, M., Sumption, M.D., Collings, E.W.

“…•Pulses at variable I/Ic resulted in stability modes unlike that seen in LTS.•3 modes were created: sub-current-sharing, standing normal zone, and slow…”
Get full text

Antioxidant enzyme activity in murine hematopoietic bone marrow following treatment with interleukin 1 alpha: influence of tumor by Johnke, R M, Abernathy, R S, Kovacs, C J, Evans, M J, Biggs, L E, Daly, B M, Loven, D P

“…To determine whether non-hematologic tumors influence the bone marrow's antioxidant enzyme response to the radioprotective cytokine interleukin 1 alpha (IL-1),…”
Get more information

Determination of plasma trace elements in tumor-bearing animals by proton-induced X-ray emission spectroscopy by Fogle, M, Daly, B, Evans, M, Justiniano, E L, Kovacs, C J, Shinpaugh, J L, Toburen, L H

“…Although altered levels of circulating essential trace elements are known to accompany malignant disease, the lack of sensitivity of conventional detection…”
Get full text

Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression by Kovacs, C J, Kerr, J A, Daly, B M, Evans, M J, Johnke, R M

“…Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) interact synergistically to enhance the restoration of stem and progenitor…”
Get more information

Cytokine profiles in patients receiving wide-field + prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate by Kovacs, C.J., Daly, B.M., Evans, M.J., Johnke, R.M., Lee, T.K., Karlsson, U.L., Allison, R., Eaves, G.S., Biggs, L.M.

“…As a result of the association between ionizing irradiation and the induction of inflammatory and fibrogenic cytokines, circulating levels of IL-1α, macrophage…”
Get full text

Interleukin-1 alpha protects against the toxicity associated with combined radiation and drug therapy by Evans, M J, Kovacs, C J, Gooya, J M, Harrell, J P

“…A dose of total body irradiation sufficient to cause 70% mortality within 30 days (9.5 Gy) and maximally tolerated doses of either adriamycin (10 mg/kg) or…”
Get more information

Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF by Kovacs, C J, Harrell, J P, Gooya, J M, Evans, M J, Johnke, R M

“…The ability of highly purified, recombinant human macrophage colony-stimulating factor (M-CSF) and recombinant human interleukin 1 alpha (IL-1) to rescue…”
Get more information

Absence of interleukin 1 alpha radioprotection in tumor-bearing animals: elevated plasma levels of prostaglandin E versus a preexisting primed marrow by Kovacs, C J, Harrell, J P, Evans, M J, Johnke, R M

“…Recombinant human interleukin 1 (IL-1) administered as a "priming" agent 24 h prior to hematopoietically lethal doses of total body irradiation (TBI) confers…”
Get more information

Altered radioprotective properties of interleukin I alpha (IL-1) in non-hematologic tumor-bearing animals by Kovacs, C J, Gooya, J M, Harrell, J P, McGowan, K M, Evans, M J

“…The radioprotective properties of IL-1 were investigated in the respective murine hosts for the Lewis lung (LLca) and EMT-6 tumors. For these studies, doses of…”
Get more information

Biochemical modulation of combined radiation and 5-fluorouracil treatment of murine tumors by d,l-leucovorin by Kovacs, C J, Dainer, P M, Evans, M J, Nyce, J

“…Experiments were designed to establish whether the response of the Lewis lung tumor (LLca) to combined 5-Fluorouracil (5-FU) and radiation could be enhanced by…”
Get more information

Lymphocyte radiosensitivity correlated with pelvic radiotherapy morbidity by Lee, Tung-Kwang, Allison, Ron R, O'Brien, Kevin F, Johnke, Roberta M, Christie, Karen I, Naves, James L, Kovacs, Charles J, Arastu, Hyder, Karlsson, Ulf L

“…To test the hypothesis that, before treatment, prostate cancer patients who demonstrate a high yield of ex vivo radiation-induced micronucleus (MN) in G(0)…”
Get more information

Temporal recovery of short-term repopulating HSC subpopulations in marrow following schedule-dependent administrations of IL-1 alpha and M-CSF by Kovacs, C J, Evans, M J, Roberts, C, Harrell, J, Abernathy, R, Gooya, J, Johnke, R M

“…Studies were carried out to establish the temporal effects of abbreviated administrations of IL-1 and IL-1 plus M-CSF as rescue agents on multipotential and…”
Get more information

Enhanced platelet recovery in myelosuppressed mice treated with interleukin-1 and macrophage colony-stimulating factor: potential interactions with cytokines having megakaryocyte colony-stimulating activity by Kovacs, C J, Powell, D S, Evans, M J, Thomas-Patterson, D, Johnke, R M

“…Studies were carried out to determine whether the combination of IL-1 + M-CSF, similar to the effect of these cytokines on neutropenia, was able to reduce the…”
Get more information

Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF) by Kovacs, C J, Harrell, J P, Evans, M J, Abernathy, R S, Roberts, C J, Johnke, R M

“…In vivo, recombinant human interleukin 1 alpha (rHuIL-1 alpha) + recombinant human macrophage colony-stimulating factor (rHuM-CSF) (IL-1 + M-CSF) effectively…”
Get more information

A cable-scale experiment to explore new materials for optimizing superconductor accelerator magnets by Kovacs, C. J., Barzi, E. Z., Turrioni, D., Zlobin, A. V., Marchevsky, M.

“…We discuss a previously commissioned system for exploring critical current pressure sensitivity in superconducting cables, the Transverse Pressure Insert, was…”
Get full text